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Abstract
We have previously reported that rhomboid domain containing 1 (RHBDD1), a mammalian rhomboid protease highly
expressed in the testis, can cleave the Bcl-2 protein Bik. In this study, we identified a multi-pass transmembrane protein,
tumor suppressor activated pathway-6 (TSAP6) as a potential substrate of RHBDD1. RHBDD1 was found to induce the
proteolysis of TSAP6 in a dose- and activity-dependent manner. The cleavage of TSAP6 was not restricted to its glycosylated
form and occurred in three different regions. In addition, mass spectrometry and mutagenesis analyses both indicated that
the major cleavage site laid in the C-terminal of the third transmembrane domain of TSAP6. A somatic cell knock-in
approach was used to genetically inactivate the endogenous RHBDD1 in HCT116 and RKO colon cancer cells. Exosome
secretion was significantly elevated when RHBDD1 was inactivated in the two cells lines. The increased exosome secretion
was verfied through the detection of certain exosomal components, including Tsg101, Tf-R, FasL and Trail. In addition, the
elevation of exosome secretion by RHBDD1 inactivation was reduced when TSAP6 was knocked down, indicating that the
role of RHBDD1 in regulating exosomal trafficking is very likely to be TSAP6-dependent. We found that the increase in FasL
and Trail increased exosome-induced apoptosis in Jurkat cells. Taken together, our findings suggest that RHBDD1 is
involved in the regulation of a nonclassical exosomal secretion pathway through the restriction of TSAP6.
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Introduction
Over the past few decades, studies have found that regulated
intramembrane proteolysis (RIP) plays an important role in
various kinds of cellular processes, including cell signaling, gene
transcription and apoptosis [1,2]. Regulated intramembrane
proteolysis is a process through which proteases cleave substrates
within their transmembrane regions. Three major intramembrane
protease families have been identified, including the metallopro-
tease-type S2P family, the c-secretase and signal peptide peptidase
family and the rhomboid proteases.
Rhomboid proteins are a family of widely conserved intramem-
brane serine proteases found from bacteria to humans [3]. In
Drosophila, they cleave the epidermal growth factor-like ligands to
regulate the EGFR signaling pathway, playing important roles in
signal transduction pathways and organism development [4,5].
The mitochondrial rhomboid protease PARL has been found to
regulate mitochondrial membrane remodeling and apoptosis [6,7].
Rhomboid proteases are also involved in para-invasion and
replication [8]. Although significant progress has been made since
their discovery approximately ten years ago, the biological
functions of most rhomboid proteases remain unclear. Few
substrates have been identified for the rhomboid proteases, and
the identification of these substrates will play a key role in
understanding the function of this intriguing family of intramem-
brane proteases. Thus, finding novel substrates is an urgent need
for the investigation of rhomboid proteases. Furthermore, only
single transmembrane proteins have been identified as substrates
of rhomboid proteases [9,10,11]. However, because so many
transmembrane proteins are multi-pass membrane proteins, there
is a question regarding whether any multi-pass transmembrane
proteins are substrates for rhomboid proteases.
TSAP6/STEAP3 was initially identified as a p53-inducible gene
implicated in apoptosis and cell cycle regulation [12,13]. TSAP6 is
a member of the six-transmembrane epithelial antigen of the
prostate (STEAP) family and facilitates ferrireductase iron uptake
in erythroid cells [14,15]. However, the most intriguing finding is
that TSAP6 plays a role in the regulation of nonclassical exosomal
secretion, which may have a broad biological significance [16,17].
Exosomes, which are 30–100 nm in diameter, are derived from
the internal vesicles of multivesicular bodies. They are secreted by
various types of cells through a nonclassical secretion pathway
[18,19]. Recent studies have highlighted the role of exosomes in
various kinds of cellular processes, including cell maturation and
differentiation, cancer progression and immune regulation
[20,21]. The function of the exosome is diverse and complicated
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targeted cells [22,23,24,25]. However, the mechanism by which
exosome secretion is regulated is still unclear. Exosomes originate
from intracellular membrane vesicles, such as endosomes,
lysosomes, and the plasma membrane, and they are secreted
through fusion with the plasma membrane [26,27]. Studies have
found that various kinds of factors and proteins can influence
exosome secretion, including calcium, DGKa, Rab family proteins
and p53 [28,29,30,31]. Interestingly, p53 has been found to
promote exosome secretion through up-regulating TSAP6 tran-
scription [16].
We investigated the function of the mammalian rhomboid
protein RHBDD1 and found that it could promote the proteolytic
cleavage and subsequent proteasomal degradation of the pro-
apoptotic Bcl-2 family member Bik [32]. We also found RHBDD1
to be implicated in the regulation of spermatogenesis [33]. Bik was
found to interact with RHBDD1 using a yeast two-hybrid screen
with RHBDD1 as bait. In addition to Bik, the multi-transmem-
brane protein TSAP6 was also identified in the screen. In this
study, we investigated whether TSAP6 was a novel substrate of
RHBDD1. We found that RHBDD1 induced the cleavage of
multi-transmembrane protein TSAP6. The major cleavage site
was mapped through mass spectrometry and mutagenesis exper-
iments. We also show that the level of TSAP6-mediated exosomal
secretion was elevated when RHBDD1 was mutated. Our findings
may help clarify the mechanism by which rhomboid proteases are
involved in the cellular secretion pathway in mammals.
Results
RHBDD1 overexpression induces the cleavage of TSAP6
Because RHBDD1 is a serine-type intramembrane protease, we
hypothesize that transmembranal TSAP6 may be a substrate of
RHBDD1. We co-transfected a Flag-tagged TSAP6 construct with
RHBDD1 or with its catalytically inactive form, RHBDD1
S144A
[32]. When transfected alone, Flag-tagged TSAP6 appeared to be
an approximately 55–70 kDa doublet on the immunoblot (Fig. 1A),
probably as a result of posttranscriptional glycosylation, as
previously reported [17]. However, the pattern of the bands of
TSAP6 was different when it was cotransfected with RHBDD1.
The intensity of the 55–70 kDa TSAP6 doublet decreased
dramatically, and a lower band (approximately 38 kDa) appeared
(Fig. 1A). However, RHBDD1
S144A did not show this effect,
indicating that the catalytic activity of RHBDD1 is essential for the
cleavage of TSAP6. In addition to the 38-kDa cleavage band, two
weaker cleavage bands were detected when the blot was exposed
for a longer period of time (Fig. 1A). The two weaker cleavage
bands were visible in most cases during our investigation of the
cleavage when exposed for longer periods. To determine whether
RHBDD1 overexpression was responsible for the cleavage of
TSAP6, the effect of the level of RHBDD1 on cleavage was
investigated. The proteolytic cleavage of TSAP6 increased
gradually when the expression of RHBDD1 was increased
(Fig. 1B). Different parts of RHBDD1 were tested for their ability
to induce the cleavage of TSAP6. RHBDD1 is mainly composed
of an N-terminal rhomboid domain and a C-terminal domain
(Fig. 1C). The N-terminal region (1–214 aa, mainly composed of
the 59–214 aa rhomboid domain) of RHBDD1 was sufficient for
the proteolysis of TSAP6, but its activity was much weaker than
full-length RHBDD1 (Fig. 1D).
The specificity of RHBDD1 for TSAP6 processing was also
evaluated using another mammalian rhomboid protease,
RHBDL2, for which several substrates have been identified
[11,34,35]. TSAP6 was cotransfected with Myc-tagged RHBDD1
or RHBDL2 into HEK-293T cells to determine whether
RHBDL2 overexpression might also result in TSAP6 cleavage
(Fig. 1E). No cleaved fragments were detected when TSAP6 was
co-expressed with RHBDL2, indicating that not all rhomboid
proteases have the ability to induce the cleavage of TSAP6.
Because TSAP6/STEAP3 is a member of STEAP family, we
determined whether other members of the family (STEAP1 and
STEAP4) could be cleaved when RHBDD1 was co-expressed.
Because some of the proteins contained N-terminal signal
peptides, rendering N-terminal tags undetectable, all of the
STEAP members were subcloned into a p3xFlag-CMV-14
construct containing a C-terminal 3xFlag tag. As shown in
Fig. 1F, no cleavage bands were detected when STEAP1 and
STEAP4 were co-expressed with RHBDD1.
Taken together, these results suggest that RHBDD1 could
specifically induce the cleavage of TSAP6, indicating that TSAP6
is a potential target of RHBDD1-mediated proteolysis.
RHBDD1-induced cleavage of TSAP6 occurs at multiple
sites
Immunoblotting showed TSAP6 to be a 55–70 kDa doublet.
This might be a result of posttranscriptional glycosylation. The
posttranscriptional modification of TSAP6 hinders the mapping of
TSAP6 cleavage sites, and is probably involved in the regulation of
TSAP6 cleavage. In order to map the cleavage sites of TSAP6 and
determine whether the posttranscriptional modification is involved
in the regulation of TSAP6 cleavage, the type of posttranscrip-
tional modification of TSAP6 first had to be examined. The
70 kDa band seemed to result from N-glycosylation because it
faded off when treated with a nonspecific N-glycosidase,
glycopeptidase F (Fig. 2A). Two potential glycosylation sites,
Asn256 and Asn344, were predicted according to the NetNGlyc
1.0 server (www.cbs.dtu.dk/services/NetNGlyc/). To determine
whether these two sites were the glycosylation sites of TSAP6, both
of the Asn residues were serially mutated to Ile, and the ability of
RHBDD1 to mediate cleavage of these mutant proteins was
determined (Fig. 2B). The TSAP6
N256I mutation significantly
reduced the glycosylated form of TSAP6, and the TSAP6
N256I+N344I
double mutation completely abolished the glycosylated band. This
confirmed that the 70 kDa band resulted from glycosylation.
However, when RHBDD1 was co-transfected, the TSAP6 mutant
proteins were cleaved normally, indicating that the cleavage did not
rely on the N-glycosylation of TSAP6.
TSAP6 is a member of the oxydoreductase family, and it
contains six transmembrane domains [15]. The total transmem-
brane domains of TSAP6 were predicted with SMART software
(smart.embl-heidelberg.de/) ( Table 1).
To locate the cleavage regions of TSAP6, the samples in Fig. 2B
were immunoblotted using an anti-V5 antibody to determine the
C-terminal cleavage fragments of TSAP6. When RHBDD1 was
co-transfected, three major C-terminal fragments were detected.
They were approximately 38 kDa, 28 kDa, and 18 kDa in mass
(Fig. 2C). We have shown that there were also three N-terminal
cleavage fragments of TSAP6 detected. They were of approxi-
mately 38 kDa, 30 kDa and 22 kDa (Figs. 1A, 2B). These cleaved
fragments were found to be relevant and added up to approxi-
mately the molecular weight of the full-length TSAP6 when the N-
terminal and C-terminal fragments were added in pairs. Thus, we
proposed that these fragments are cleaved fragments within three
different regions. The major cleavage site is near the C-terminal
one, generating an N-terminal 38-kDa cleaved fragment. This site
was chosen for investigation of the mechanism of cleavage.
Proteolysis of TSAP6 by RHBDD1
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To determine the cleavage sites of TSAP6, mass spectrometric
analysis was used. Flag-tagged N-terminal and C-terminal
cleavage fragments were generated by co-expressing the
pcDNA6-Flag-TSAP6 or p3xFlag-TSAP6 constructs with
RHBDD1-HA in 293T cells. The fragments were then immuno-
precipitated with anti-Flag agarose, separated with SDS-PAGE,
and stained with Coomassie blue R-250 (N-terminal fragment,
Fig. 3A; C-terminal fragment, not shown). The purified fragments
were digested and subjected to mass spectrometric analysis. As
shown in Fig. 3B, a series of N-terminal peptides (yellow) and C-
terminal peptides (green) were identified, with a N-terminal
peptide (YSFCLPLR) located in the C-terminal of the third
transmembrane domain (TM3). One peptide (YDLVNLAVK)
that was adjacent to the TM3 region was identified in C-terminal
fragment. The resulting peptides indicated that a cleavage site
might lie in the short sequence (RAHR) between the two peptides.
In order to confirm that the region contains a RHBDD1-
induced cleavage site, we mutated a series of residues of TSAP6
into phenylalanine and leucine (Fig. 4A). We found that the
cleavage was dramatically reduced when residues around the C-
Figure 1. RHBDD1 overexpression induces the cleavage of TSAP6. A. RHBDD1 mediated proteolytic processing of TSAP6 in an enzymatic
activity-dependent manner. Upon co-expression of TSAP6-Flag and RHBDD1-HA or RHBDD1
S144A-HA in HEK-293T cells, the cleaved fragments were
observed only with RHBDD1 overexpression. Note that three cleaved fragments (black arrowheads) were detected when the blot was exposed for a
longer period of time. B. Dose dependency of RHBDD1-induced cleavage of TSAP6. The lysates of HEK-293T cells transfected with the indicated
amounts of RHBDD1-HA and TSAP6-Flag constructs were blotted using anti-Flag and anti-HA antibodies. The cleaved fragments are indicated with
black arrowheads. C. RHBDD1 and its truncated forms. D. Determination of the cleaving ability of different regions of RHBDD1 on TSAP6. The lysates
of 293T cells transfected with TSAP6 and empty vector or RHBDD1-HA, RHBDD1C-HA, RHBDD1N-HA, and RHBDD1
S144A-HA (here designated as
S144A) were seperated with 10% SDS-PAGE and blotted with the indicated antibodies. E. RHBDL2 was not found to cleave TSAP6. F. RHBDD1 did not
promote proteolysis of STEAP1 and STEAP4. 3xFlag-tagged TSAP6, STEAP1 or STEAP4 constructs were co-transfected with empty vectors or RHBDD1-
HA. The cell lysates were blotted with indicated antibodies. The cleavage band of TSAP6 was shown with black arrowhead. A non-specific band was
indicated with an asterisk.
doi:10.1371/journal.pone.0037452.g001
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mutations, Fig. 4B). However, mutations in other regions did not
exert such a significant influence. L325F mutation significantly
reduced the cleavage, while cleavage with 326-3L mutant protein
was barely detectable, suggesting that the region around the C-
terminal of the TSAP6 TM3 domain possesses a RHBDD1-
induced cleavage site.
The inactivation of endogenous RHBDD1 increases
TSAP6-mediated exosome secretion
TSAP6 has been reported to regulate the nonclassical exosomal
secretion pathway [17]. Because RHBDD1 induces cleavage in
TSAP6 in cells, we evaluated the involvement of RHBDD1 in the
TSAP6-mediated nonclassical secretion pathway.
Recently, a recombinant-adeno-associated virus-based homolo-
gous recombination-mediated somatic cell knock-in approach was
developed to introduce various kinds of alterations to endogenous
loci [36]. RHBDD1 possesses a GFSGV motif in its rhomboid
domain, and this motif is critical to its enzymatic activity [32]. For
this reason, we selected the knock-in approach to introduce two
point mutations, G142A and S144A, into the endogenous loci of
RHBDD1 in HCT116 colon cancer cells (Fig. 5A). After two
rounds of targeting, HCT116 cells with mutant version of both
alleles (RHBDD1-mt) were generated. They were verified using
PCR analysis and DNA sequencing (data not shown). The total
mRNA in HCT116-mt cells was extracted and reverse-transcribed
into cDNA. Then, the cDNA encoding RHBDD1 was amplified
and sequenced. This confirmed the mutations (Figure. S1). When
immunoblotted with an anti-RHBDD1 antibody, the RHBDD1
protein was found to be barely detectable in RHBDD1-mt cells
(Fig. 5C). This low level of expression was probably the result of
rapid proteasomal degradation, as indicated by the fact that the
proteasome inhibitor MG132 partially restored RHBDD1 in the
mutated cells (data not shown). To investigate endogenous
Figure 2. RHBDD1-induced TSAP6 cleavage occurs at multiple sites. A. Glycopeptidase F treatment of TSAP6. HEK-293T cell lysates
transfected with TSAP6-Flag were treated with or without glycopeptidase F for 20 h at 37uC under denaturing conditions and blotted using an anti-
Flag antibody. The posttranscripitional modified form of TSAP6 faded off (white arrowhead) after Glycopeptidase F treatment. B. RHBDD-mediated
TSAP6 cleavage was not found to be dependent on the glycosylation of TSAP6. TSAP6 or its glycosylation site-mutated forms, TSAP6
N256I and
TSAP6
N256I+N344I, were co-transfected with control vector or a RHBDD1-HA-expressing vector in HEK-293T cells. At 36 h after transfection, the cells
were lysed and immunoblotted using anti-Flag and anti-HA antibodies. The cleaved fragments of TSAP6 are indicated with black arrowheads.
C.Immunodetection of RHBDD1-cleaved C-terminal fragments of TSAP6. RHBDD1-mediated TSAP6 cleavage generated three major fragments (black
arrowheads). Two other fragments indicated with asterisks were the glycosylated form because they disappeared in the TSAP6
N256I+N344I construct.
doi:10.1371/journal.pone.0037452.g002
Table 1. Predicted transmembrane domains of TSAP6 using
SMART software.
Predicted transmembrane domains
Number Begin End
TM1 209 231
TM2 258 280
TM3 305 327
TM4 359 381
TM5 394 416
TM6 431 453
doi:10.1371/journal.pone.0037452.t001
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However, the antibody was shown to be rather poor in quality
and there were non-specific bands in the blot, despite that it did
recognize bands corresponding to TSAP6 (Figure S2).
As shown in Fig. 5C, the level of TSAP6 was found to be
significantly increased in RHBDD1-mt cells, which was probably
the result of reduced RHBDD1-mediated proteolysis of endoge-
nous TSAP6. Because the change in the level of TSAP6 could also
have resulted from increased gene transcription, the relative
mRNA level of TSAP6 was quantified using RT-PCR. No
significant differences were found (Fig. 5D). Similar results were
also observed with Bik, and the mRNA of RHBDD1 was found to
be slightly elevated in RHBDD1-mt cells. In this way, abrogation
of RHBDD1-mediated proteolysis seemed to be responsible for the
increase in TSAP6 protein level in RHBDD1-mt HCT116 cells.
Next, we analyzed whether RHBDD1 inactivation had an
influence on TSAP6-mediated exosome secretion. According to a
published protocol for exosome isolation and characterization, we
isolated the secreted exosomes in wild-type and RHBDD1-mt
HCT116 cells through differential ultracentrifugation approach
[37]. The secreted exosome proteins were quantified and found to
be significantly elevated when RHBDD1 was mutated (Fig. 5B).
The experiment was repeated at least four times, and similar
results were obtained. Because some non-specific contaminations
might be associated with exosomes purified by differential
ultracentrifugation, we further detected two exosomal compo-
nents, tumor susceptibility gene 101 (Tsg101) and transferrin
receptor (Tf-R) to determine whether there was an increase of
exosome components in the samples. Gp96 (glycoprotein 96) was
used as a control to determine whether there was any contam-
ination with cellular debris in exosome samples (Fig. 5C). The
exosomal components Tsg101 and Tf-R were found to be
significantly elevated in exosome samples from RHBDD1-mt
cells, indicating that RHBDD1 inactivation could significantly
increase the quantity of total secreted exosomes. Besides, the
isolated exosome samples were evaluated through sucrose gradient
ultracentrifugation, which is an accurate method to define the
exosomal fraction [37]. Both of the exosomal components were
found to accumulate mostly in the 1.08–1.23 g/ml fractions,
indicating that the components are located in exosome fractions
(Fig. 5E).
In order to determine whether elevated exosome secretion
caused by RHBDD1 inactivation was reproducible in other types
of cells, we introduced the same mutations into endogenous
RHBDD1 in RKO colon cancer cells. Exosome secretion was
assayed in wild-type (RKO wt) and RHBDD1-mt (RKO mt) cells
(Fig. 6A). The exosome components, Tsg101 and Tf-R, were also
detected in equal amount of exosome samples (Fig. 6B). Both of
total secreted exosomes and the exosomal components were
elevated significantly when RHBDD1 was mutated. These
Figure 3. Determination of the major cleavage site within TSAP6 through mass spectrometric analysis. A. Immunoprecipitation of
TSAP6 N-terminal fragments. The cell lysate of HEK-293T cells transfected with pcDNA6-Flag-TSAP6 and empty vector or RHBDD1-HA was
immunoprecipitated with anti-Flag agarose. The immunoprecipitates were separated with SDS-PAGE and stained with Coomassie blue R-250. A 38-
kDa protein band was observed when RHBDD1 was co-expressed. B. Mass spectrometric analysis of the resulting peptides. The TM3 domain of TSAP6
is underlined. The identified N-terminal peptides are marked in yellow, and the peptides identified from C-terminal fragment are shown in green. The
predicted cleavage region is shown in italics.
doi:10.1371/journal.pone.0037452.g003
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RKO cells had very similar influence on exosome secretion. In this
way, RHBDD1 mutation was shown to be associated with elevated
exosome secretion, indicating that RHBDD1 might have a role in
the regulation of exosome secretion.
It has been documented that TSAP6 played a role in
regulating exosome secretion. Thus, we speculated that
RHBDD1 might facilitate the regulation of exosome secretion
through modulating the level of TSAP6 in cells. In order to
determine whether the elevated exosome secretion in RHBDD1
mutant cells was TSAP6-dependent, we knocked down the
expression of TSAP6 in wild-type and RHBDD1-mt HCT116
cells, and assayed exosome secretion in these cells. Exosome
secretion was found to be significantly decreased in both wild type
and RHBDD1-mt HCT116 cells when TSAP6 was knocked
down (Fig. 6C). More importantly, the ratio of secreted exosomes
between RHBDD1-mt and wild-type cells was reduced dramat-
ically when TSAP6 was knocked down, from 2.05 (21.6 mg/
10.5 mg) to 1.25 (5.5 mg/4.4 mg), which is consistent with the
reduced difference in TSAP6 expression. The differential levels of
exosomal components in wild type and RHBDD1-mt cells were
also reduced significantly when TSAP6 was knocked down
(Fig. 6D). These findings indicated that the elevation of exosome
secretion by RHBDD1 inactivation was very likely to be TSAP6-
dependent.
RHBDD1 inactivation promotes exosome-induced
apoptosis in Jurkat cell
Recent studies have highlighted exosomes as a multifunctional
organelle with biological significance. Exosomes have been found
to participate in cell-cell communication, tumor progression and
immune regulation through specialized exosomal components.
Recently, FasL and Trail have been identified as exosomal
components secreted from cancer cells. They can cause apoptosis
in T lymphocytes through the activation of their corresponding
receptors [24]. For this reason, we determined whether exosomes
secreted from HCT116 cells also contained these ligands and
whether exosomes secreted from RHBDD1-mt cells had enhanced
biological activity relative to wt HCT116 cells. Jurkat cells were
used as the model for T lymphocytes in this assay [24].
As shown in Fig. 7A, FasL and Trail were both detected in the
exosome samples. In addition, levels of both ligands were
increased in exosomes secreted from RHBDD1-mt cells. Further-
more, the exosomes from RHBDD1-mt cells had significantly
enhanced ability to induce apoptosis in Jurkat cells. This ability
appeared to be primarily dependent on FasL and Trail because
FasL and Trail antibodies dramatically attenuated the apoptotic
effect of exosomes (Fig. 7B). Taken together, these results show
that RHBDD1 has influences on the secretion of the exosomal
components FasL and Trail, which partly contribute to the role of
exosomes in inducing the apoptosis in Jurkat cells.
Discussion
It has been a decade since rhomboid proteases were identified,
and great progress has been made since the discovery of this
intriguing intramembrane protease family [38]. In the present
study, we show that TSAP6 was cleaved specifically in response to
RHBDD1 overexpression. Further, we identified a cleavage site in
the C-terminal region of TSAP6 TM3 domain, which resembles
an intramembrane cleavage site. Finally, endogenous TSAP6
became enriched when RHBDD1 was inactivated, indicating that
RHBDD1 could restrict the level of endogenous TSAP6 protein in
cells. Taken together, these results indicate that TSAP6 is a target
of RHBDD1-induced proteolysis. Besides, TSAP6 was identified
through yeast two-hybrid assay with RHBDD1 as bait, implicating
that TSAP6 might have direct binding with RHBDD1 and was
very probably catalyzed directly by the protease (Fig. 8). However,
the substrate-recognition-mechanisms of rhomboid proteases are
diverse and complicated and the model for how RHBDD1
recognizes and cleaves its substrates has not yet been proposed.
Thus, whether TSAP6 is directly cleaved by RHBDD1 remains to
be a question of doubt and needs to be verified when there is better
understanding for the protease.
To data, all well-confirmed rhomboid substrates are type I
membrane proteins. However, evidences indicated that other
types of transmembrane proteins might also be the substrates of
rhomboid proteases. Type II membrane protein Star is cleaved in
transmembrane region in response to Rhomboid-1 overexpression
[39]. GlpG was shown to cleave synthetic multi-pass membrane
proteins [40]. In this study, intact multi-pass membrane protein
was found to might also be cleaved by rhomboids. Intriguingly,
both of the proposed multi-pass membrane proteins seemed to be
cleaved in type II orientation. These findings indicated that
rhomboid proteases might have a broader substrate profile than
previously supposed.
We found that RHBDD1 inactivation enriched endogenous
TSAP6 and increased exosome secretion in cells. Because it has
been established that TSAP6 promotes exosome secretion, it is
highly possible that the role for RHBDD1 in regulating exosome
Figure 4. Location of the cleavage region of TSAP6 with
mutagenic analysis. A. A series of mutations within and around TM3
was constructed. The mutated residues are shown in bold. B. The
cleavage of TSAP6 and its mutant forms. The cleaved fragments are
indicated with black arrowheads.
doi:10.1371/journal.pone.0037452.g004
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down the endogenous TSAP6, the increase in exosome secretion
induced by RHBDD1 inactivation was reduced. This was
consistent with the idea that TSAP6 is a possible intermediate
for RHBDD1’s regulatory role in exosome secretion.
A large percentage of rhomboid proteases are involved in the
cellular secretion pathway. Our findings indicate that RHBDD1 is
involved in the regulation of exosomal secretion probably through
modulating the amount of TSAP6. This might play a role in
inducing apoptosis in T lymphocyte. In this respect, the exosomes
secreted from cancer cells might contribute to immune suppression
and cancer progression, as previously reported [41,42]. However,
an increasing number of studies have indicated that exosomes are
multi-functional organelles with biological significance. The
biological functions of exosomes are complicated and depend on
various factors, including the numerous components of the
exosomes, the cells from which they originate, and the cells with
which they interact. For example, exosomes originating from
immune cells, such as dendritic cells and B cells, have been found
to play a role in regulating antigen presentation, which might
promote immune systems to target cancer cells [43,44]. In this
way, the biological consequence of RHBDD1 in affecting exosome
secretion remains unclear. More work must be performed to
determine with certainty the biological significance of exosome
secretion and how RHBDD1 plays a role in this regard.
Materials and Methods
Ethics statement
The Animal Ethics Committee of National Research Institute
for Family Planning Beijing approved the animal experimentation
protocols. All animal experiments were performed in accordance
Figure 5. Analysis of exosome secretion in wild-type and RHBDD1-mt HCT116 cells. A. A schematic diagram of the targeting motif of
RHBDD1 knock-in. B. Quantitative analysis of total exosomes secreted from 2610
7 HCT116 cells for 16 h. C. Immunodetection of Tsg101 and Tf-R
contents in 4 mg of exosomal proteins from wild-type and RHBDD1-mt HCT116 cells. TSAP6 expression was normalized with GAPDH and shown
below (** P,0.01). D. Real-time analysis of the relative mRNA levels of RHBDD1, TSAP6 and Bik in wild-type and RHBDD1-mt HCT116 cells. E. Western
blot analysis of Tsg101 and Tf-R proteins on fractions collected from 40 mg of total exosome samples from wt and RHBDD1-mt HCT116 cells
processed on a 0.25–2.5 M sucrose gradient.
doi:10.1371/journal.pone.0037452.g005
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as established by the Chinese Council on Animal Care. All the
protocol numbers we received from the Animal Ethicics Commit-
tee of National Research Institute for Family Planning are as
follows: 20090316, 20091016 and 20100505.
Cell Culture, cDNAs, and Transfection
HEK-293T (Cell Resource Center, PUMC) cells were cultured
in Dulbecco’s modified Eagle’s medium (Invitrogen) supplemented
with 10% fetal calf serum. HCT116 (Cell Resource Center,
PUMC) and RKO (Cell Resource Center, PUMC) cells were
cultured in Iscove’s modified Dulbecco’s medium (Invitrogen)
supplemented with 10% fetal calf serum (Invitrogen). The 293T
cells were transfected using Entranster D (Engreen Biosystem Co,
Ltd.). Jurkat cells (Clone E6-1, Cell Resource Center, PUMC)
were cultured in RPMI-1640 medium supplemented with 10%
fetal calf serum (Hyclone).
The cDNA encoding TSAP6 was amplified from a 293T cDNA
library using PCR using the following primers: sense, 59-
ATCAAGCTTACCATGCCAGAAGAGATGGAC-39, and an-
ti-sense, 59-ATCCTCGAGGTGACCGTACGTGGCTCGT-
CTTCTCGGCC-39. A Flag tag (DYKDDDDK) was added in
the NheI and HindIII sites of the pcDNA6-V5/His-B plasmid
(Invitrogen). The TSAP6 PCR product was subcloned into the
Figure 6. Exosome secretion in RKO cells and TSAP6 dependency of RHBDD1’s role in exosome secretion. A. Total exosome proteins
secreted from 2610
7 wild-type (RKO wt) and RHBDD1-mt (RKO mt) RKO cells in 16 h. B. Immunodetection of exosome components and cellular
TSAP6 in wt and mt RKO cells. C. Wild-type and RHBDD1-mt HCT116 cells infected with control shRNA (con) or TSAP6 shRNA (TSAP6i) lentivirus were
plated and assayed for exosome secretion. Total exosomes secreted from 1610
7 HCT116 cells were measured. D. Western blot analysis of cell lysates
and exosome samples. Cell lysates or exosome samples secreted from 2610
6 cells were seperated with SDS-PAGE and blotted with indicated
antibodies.
doi:10.1371/journal.pone.0037452.g006
Figure 7. Exosome samples secreted from RHBDD1-mt cells showed elevated ability to induce Jurkat cell apopotosis. A.
Immunodetection of FasL and Trail in 4 mg of exosomal proteins secreted from wild-type and RHBDD1-mt HCT116 cells. B. The apoptotic rate of
Jurkat cells after incubation with exosome samples purified from wild-type or RHBDD1-mt HCT116 cells.
doi:10.1371/journal.pone.0037452.g007
Proteolysis of TSAP6 by RHBDD1
PLoS ONE | www.plosone.org 8 May 2012 | Volume 7 | Issue 5 | e37452HindIII and XhoI sites of the pcDNA6-Flag/V5 construct. The
TSAP6 mutations were constructed using overlapping extension
PCR. RHBDD1 and its S144A mutation constructs were
described previously [32]. Myc-tagged RHBDD1- and
RHBDL2-expressing vectors were constructed by inserting the
coding sequences into the HindIII and XhoI sites of pcDNA6-
Myc/His-B (Invitrogen). The C-terminal 3xFlag-tagged STEAP1,
STEAP4 and TSAP6 constructs were generated by inserting the
coding sequences into the HindIII and XbaI sites of p3xFlag-
CMV-14 (Sigma).
Antibodies, Co-immunoprecipitation, and
Immunoblotting
The following antibodies were purchased: rabbit polyclonal anti-
RHBDD1 (HPA013972, Sigma), Flag (F3165, Sigma), Myc (sc-40,
Santa Cruz), HA (H3663, Sigma), GAPDH (TA-08, ZSbio), Gp96
(bs-0194R, Bios Biotech), Tsg101(bs-1365R, Bios Biotech), Tf-R
(sc-32272, Santa Cruz), FasL (#4273, Cell Signaling, for western
blot analysis), FasL (556371, BD Biosciences, for antibody-blocking
assays), Trail (550515, BD Biosciences), and HRP-conjugated goat
anti-mouse and goat anti-rabbit antibodies (ZSbio). The monoclo-
nal anti-TSAP6 antibody was generated through the immunization
of a BALB/c mouse (Laboratory Animal Centre of PUMC, Beijing)
witha 66His-tagged purified recombinantprotein correspondingto
the N-terminal 1-126-amino acid fragment of human TSAP6.
Hybridomas were screened by an indirect enzyme-linked immuno-
sorbent assay (ELISA) using the 66His-tagged recombinant
protein. Immunoblotting assays were performed as described
previously [32].
Immunoprecipitation and mass spectrometric analysis
5610
6 293T cells transfected with 8 mg RHBDD1-HA and 8 mg
pcDNA6-Flag-TSAP6 or p3xFlag-TSAP6 plasmids were lysed in
lysis buffer (20 mM Tris, pH 7.5, 200 mM NaCl, 1% NP-40, 10%
glycerol, 1 mM DTT and completed protease inhibitor cocktail
(Roche)). They were then immunoprecipitated with 40 ml anti-
Flag slurry ( A2220, Sigma). The immunoprecipitates were
separated with 10% SDS-PAGE and stained with Coomassie
blue R-250.
The protein bands were cut and used for in-gel digestion with
trypsin. The resulting peptides were analyzed with LTQ Orbitrap
Velos mass spectrometer (Thermo Scientific).
RNA extraction and relative quantitative real-time PCR
RNA was extracted from HCT116 cells using TRIzol reagent
(Invitrogen) according to the manufacturer’s instructions. The
total RNA was reverse-transcribed into cDNA using ReverTra
Ace-a (Toyobo). Relative quantitative RT-PCR was performed
using the TaqMan Universal PCR Master Mix (Applied Biosys-
tems) on an iCycler IQ5 PCR machine (Bio-Rad). The primers for
RT-PCR were as follow: RHBDD1: sense, 59-CTCTGGGACC-
GAGGAAATACC-39, and anti-sense, 59-ACCTCACTGGC-
TATCGAATCTGT-39.;TSAP6: sense, 59-TGCAAACTCGCT-
CAACTGGAG-39, and anti-sense, 59-GAAGGTGGGAGG-
CAGGTAGAA-39; Bik: sense, 59-ACCATGGAGGTTCTTG-
GCA-39, and anti-sense, 59-AGGCTCACGTCCATCTCGTC-
39; Actin: sense, 59-AGGCCAACCGCGAGAAGAT-39, and anti-
sense, 59-TCACCGGAGTCCATCACGAT-39.
Exosome secretion and isolation
Exosome isolation and characterization assays were carried out
in accordance with a published protocol [37]. For the exosome
secretion assay, 2610
7 HCT116 or RKO cells (1610
7 cells were
used in TSAP6 knockdown assay) were plated and cultured for
24 h. The cells were incubated with exosome-free IMDM
medium, which was prepared using ultracentrifugation at
100,000 g for 16 h at 4uC. After 16 h of incubation, the medium
was collected and centrifuged twice at 300 g for 5 min to remove
cell debris. The medium was further centrifuged at 12,000 g for
30 min and filtered through a 0.22 mm filter. Exosome pellets were
isolated using centrifugation at 100,000 g for 2 h at 4uCi na
Beckman L-100 XP Ultracentrifuge. The isolated exosomes were
washed with a large volume of PBS and resuspended in 100 ml
PBS. The amount of exosomes secreted was quantified using a
BCA protein assay kit (Thermo Scientific). The sucrose gradient
used to purify exosomes was similar to a method described
previously [17]. Briefly, 40 mg of total exosomes was centrifuged at
100,000 g for 16 h in 2.2 ml of a 0.25 M–2.5 M sucrose gradient
at 4uC in a Beckman LT-100 Ultracentrifuge. Each fraction
(300 ml) was added with 75 mlo f5 6SDS sample buffer, boiled for
5 min and analyzed using western blotting.
Deglycosylation assay
The treatment of TSAP6 with glycopeptidase F (Takara
Biotech) was performed under denaturing conditions according
to the manufacturer’s protocol.
Exosome-induced apoptosis assay
16105 Jurkat cells were incubated with 5 mg of purified
exosome samples for 60 h, stained with annexin-V-FITC/PI
(Neobioscience) and analyzed using an Accuri C6 flow cytometer
(BD Biosciences). For antibody-blocking assays, the exosome
samples were pre-incubated with 1 mg/ml anti-FasL and anti-Trail
antibodies for 30 min.
TSAP6 RNAi assay
Lentivirus human TSAP6-targetting oligonucleotides were
synthesized and packaged by GENECHEM Inc. The TSAP6
targeting sequences was: 59- GAGGGAGTTCAGCTTCGTTCA
-39. HCT116 colon cancer cells were infected with TSAP6-
shRNA-lentivirus or control shRNA virus. At 72 h after infection,
the cells were subjected to exosome secretion assay.
Supporting Information
Figure S1 Alignment of knock-in cDNA and the coding
sequence of RHBDD1. Note that two mutations were detected
in the knock-in cDNA of RHBDD1, which codes an inactivated
form of RHBDD1.
(DOC)
Figure 8. A hypothetical schematic diagram of RHBDD1
mediated TSAP6 proteolysis.
doi:10.1371/journal.pone.0037452.g008
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lysates. Protein samples were seperated with SDS-PAGE and
blotted with monoclonal anti-TSAP6 antibody. Line 1, HCT116
cell lysate. Line 2, 293T cell lysate transfected with TSAP6-Flag.
(TIF)
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